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Abstract  
The development of non-animal methods for skin sensitization testing is an urgent challenge. Some of the most promising in vitro approaches are based on 
the analysis of phenotypical and functional modifications induced by sensitizers in dendritic cell models. In this work, we evaluated, for the first time, a fetal 
skin-derived dendritic cell line (FSDC) as a model to discriminate between sensitizers and irritants, through analysis of their effects on CD40 and CXCR4 
protein expression. The chemicals concentrations were chosen based on a slight cytotoxicity effect (up to 15%).Protein levels were evaluated by Western blot 
and immunocytochemistry, after stimulation with the skin sensitizers 2,4-dinitrofluorobenzene  
(DNFB), 1,4-phenylenediamine (PPD) and nickel sulphate (NiSO4 ), the non-sensitizer 2,4-dichloronitrobenzene (DCNB), and the irritants sodium  
dodecyl sulphate (SDS) and benzalkonium chloride (BC). All sensitizers tested increased CD40 and CXCR4 levels. In contrast, irritants decreased  
both proteins levels, with a more pronounced effect on CXCR4. In agreement with these results, dendritic cells derived from human peripheral blood  
monocytes-derived dendritic cells (MoDC) showed a similar response pattern to the skin sensitizer and irritant tested, PPD and SDS, respectively.  
In conclusion, evaluation of CD40 and CXCR4 proteins in chemical-treated FSDC may represent a useful tool in a future in vitro test for sensitizing  
assessment.  
© 2007 Elsevier Ireland Ltd. All rights reserved.  
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1.Introduction 
Allergic contact dermatitis (ACD), a delayed-type 
hypersensitivity reaction caused by contact of the skin with low molecular 
weight reactive chemicals (haptens), is a common occupational and 
environmental health problem, affecting approximately 1% of the 
general population (Divkovic et al., 2005; Ryan et al., 
2005).Currently, the assessment of the sensitizing potential of 
chemicals is mainly based on animal tests, such as the local lymph 
node assay (LLNA) (Kimber et al., 1995), the guinea pig 
maximization test (GPMT) (Magnusson and Kligman, 1969) and the 
Buehler test (Buehler, 1965). However, the publication of the 7th 
Amendment to the European Cosmetics Directive raised 
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the need of developing alternative in vitro/in silico methods (EC, 
2003; Basketter et al., 2007). 
Some of the most promising in vitro approaches explore the 
interactions of contact allergens with dendritic cells (DC), which are 
crucial in the induction phase of ACD (Ryan et al., 
2005).Langerhans cells (LC), the main antigen-presenting cells of 
the skin, typify the sentinel role of immature DC, translating 
changes in their local microenvironment into specific immune 
responses. Following an encounter with an haptenized-peptide, LC 
become activated, leave the skin, migrate via the afferent lymphatics 
to the draining lymph nodes and differentiate into fully mature DC, 
able to effectively present antigens to na¨ ve T-cells. During 
maturation, LC experiment morphological, functional and phenotypical 
changes, including up-regulation of class II MHC molecules, co-
stimulatory molecules such as CD83, CD80, CD86, CD40 and the 
adhesive molecules CD54 and CD58 (Banchereau et al., 2000). 
These changes were early  
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seen as opportunities to correlate the sensitizing potential of 
chemicals with their ability to activate DC, and have been  
explored by several groups in the last years (reviewed by Ryan et 
al., 2005). 
Since LC constitute only 1-3% of all epidermal cells and  
no LC line has been established until now, DC derived from  
CD34+ progenitor cells (Strunk et al., 1996), or from peripheral  
blood mononuclear cells (PBMC) (Sallusto and Lanzavecchia,  
1994)have been used as DC surrogates. These DC-like cells have  
been used to evaluate the effect of sensitizers through measure 
ment of the surface expression of HLA-DR, CD54, CD83, CD86  
(Rougier et al., 2000; Tuschl et al., 2000; Hulette et al., 2002;  
Staquet et al., 2004), production of cytokines or chemokines  
(Aiba et al., 1997; Ebner et al., 1998; Coutant et al., 1999; Jugde  
et al., 2005), and through evaluation of tyrosine phosphorylation  
or activation of the MAPK signalling pathways (Becker et al.,  
1997; Kuhn et al., 1998; Arrighi et al., 2001). Another recent  
approach, focused on holistic transcript profiling of DC exposed  
to sensitizers, in which total mRNA profile was examined, pro 
vided new information about genome-wide changes that could  
be helpful in the identification of novel biomarkers of DC acti 
vation (Ryan et al., 2004; Gildea et al., 2006; Schoeters et al.,  
2006). 
To circumvent the inexistence of a standardized protocol for 
generating DC-like cells and the inherent variability of immature DC 
obtained from human donors, several groups have tried to use 
human myeloid cell lines, namely THP-1 (Ashikaga et al., 2002; 
Hulette et al., 2002; Yoshida et al., 2003), U937 (Python et al., 
2007), MUTZ-3 (Azam et al., 2006), or the murine XS52 cell line 
(Neisius et al., 1999; Herouet et al., 2000), as tools for the in vitro 
identification of contact sensitizers. 
However, currently, there are no validated in vitro methods  
for the identification of skin sensitizing chemicals, and basic  
immunological research is still necessary to identify new can 
didates to be tested for this purpose. Some of the promising  
parameters to be evaluated are intracellular signalling pathways  
activated by skin sensitizers, the modulation of the plasma mem 
brane expression of proteins and cell-cell signalling molecules,  
and also changes in the antigen uptake process in DC (Basketter  
et al., 2007). 
In this context, the aim of the present study was to  
evaluate the effect of different contact sensitizers, namely  
2,4-dinitrofluorobenzene (DNFB), 1,4-phenylenediamine 
(PPD) and nickel sulphate (NiSO4 ), the non-sensitizer 2,4 
dichloronitrofluorobenzene (DCNB), and the irritants sodium  
dodecyl sulphate (SDS) and benzalkonium chloride (BC), 
on the protein levels of the chemokine receptor CXCR4 and the co-
stimulatory molecule CD40, in DC. As experimental model of DC 
we used a mouse fetal skin-derived dendritic cell line (FSDC), 
which has been previously used as a model of immature DC (Mann 
et al., 2002; Egan et al., 2004). This cell line has morphological, 
phenotypical and functional  
characteristics of Langerhans cells (Girolomoni et al., 1995), and, 
in contrast to other DC-like cell lines, is cultured in the absence of 
exogenous growth factors. In addition, the results obtained in this 
cell line were confirmed on human peripheral blood monocyte-
derived dendritic cells (MoDC). 
2.Materials and methods 
2.1.Materials 
DNFB and DCNB were obtained from Sigma-Aldrich Qu´mica (Madrid,  
Spain), NiSO4 and BC were purchased from Sigma Chemical Co. (Madrid,  
Spain) and PPD from Aldrich Chemical Co. (Madrid, Spain). Lipopolysac 
charide (LPS) from Escherichia coli (serotype 026:B6) was obtained from  
Sigma Chemical Co. (St. Louis, MO, USA). Fetal calf serum and trypsin  
were purchased from Gibco (Paisley, UK), GM-CSF and IL-4 were from  
PeproTech (London, UK), and the protease inhibitor cocktail and the mono 
clonal anti-actin antibody were obtained from Roche (Carnaxide, Portugal).  
The rabbit polyclonal antibody against CXCR4 was purchased from Abcam  
(Cambridge,UK) and the anti-CD40 antibody was from R&D Systems (Min 
neapolis, MN). Lymphoprep was from Axis-Shield (Oslo, Norway) and the  
MACS colloidal supermagnetic microbeads conjugated with anti-human CD14  
monoclonal antibody (CD14 microbeads) were purchased from Miltenyi Biotec  
Inc. (Bergisch Gladbach, Germany). The Lab-Tek Chamber Slides were pur 
chased from Nunc GmbH & Co. KG (Wiesbaden, Germany) and the Vectashield  
mounting medium was from Vector, Inc. (Burlingame, CA, U.S.A.) The alkaline  
phosphatase-linked secondary antibodies and the enhanced chemifluorescence  
(ECF) reagent were obtained from GE Healthcare (Carnaxide, Portugal), and  
the polyvinylidene difluoride (PVDF) membranes were from Millipore Corpora 
tion (Bedford, MA). All other reagents were from Sigma Chemical Co. (Madrid,  
Spain). 
2.2.Generation of peripheral monocyte-derived DC (MoDC) 
Peripheral blood mononuclear cells were obtained from fresh EDTA treated  
blood of healthy human donors (after their informed consent), using Lym 
phoprep density gradient centrifugation. Briefly, blood was diluted with equal  
parts of PBS and 30 ml samples were seeded in 50 ml Falcon tubes contain 
ing 15 ml of Lymphoprep. The tubes were centrifuged at 600 × g, for 30 min  
at 20 ◦C, and the mononuclear fraction was collected and washed with PBS  
supplemented with 0.5% FCS and 2 mM EDTA (MACS buffer). After count 
ing, PBMC were resuspended in the appropriate volume of MACS buffer and  
incubated with CD14 microbeads, for 20 min at 4 ◦C. After washing, CD14+  
cells were separated by positive selection in a magnetic cell separator column.  
CD14+ monocytes were cultured for 7 days, in RPMI-1640 medium supple 
mented with 10% (v/v) fetal calf serum, 100 g/ml streptomycin, 100 U/ml 
penicillin, 800 U/ml IL-4 and 1000 U/ml GM-CSF, in a humidified incubator  
with 5% CO2 /95% air, at 37 ◦C. One half of the culture medium was replaced  
on day 3 and day 5, by fresh medium containing the same cytokines concentra 
tions. The phenotype of these cells at day 7 is consistent with an immature DC  
phenotype: HLA-DR+ , CD1a+ , CD83− , CD80low and CD86low (Hulette et al.,  
2002). 
2.3.Culture of FSDC 
The fetal mouse skin-derived dendritic cell line, kindly supplied by Dr. G.  
Girolomoni (Laboratory of Immunology, Instituto Dermopatico dell’Imacolata,  
IRCCS, Rome, Italy), is a skin dendritic cell precursor with antigen presenting  
capacity. This cell line was previously characterised and had a surface phe 
notype consistent with a Langerhans cell progenitor (H-2d.b+ , I-Ad.b+ , CD54+ ,  
MHCII+ , MHCI+ , CD11c+ , CD11b+ , B7.2+ , CD44+ B220, CD3) (Girolomoni  
et al., 1995), being this phenotype actually confirmed in our lab for the most  
important of these surface markers (data not shown). The FSDC did not require  
exogenous growth factors for their continued proliferation when cultured in  
serum-containing medium, having a doubling time of about 48 h. The cells were  
used after reaching 70-80% confluence, which occurs approximately every  
3days. After 45 passages the cells were discarded. FSDC are adherent and  
present a morphology consistent with a DC type, having an irregular shape  
and many surface projections arising from the cell. The cells were cultured in  
endotoxin-free Iscove’s Modified Dulbecco’s Medium (IMDM), supplemented  
with 10% (v/v) fetal calf serum, 1% (w/v) glutamine, 3.02 g/l sodium bicarbon 
ate, 100 g/ml streptomycin and 100 U/ml penicillin, in a humidified incubator 
with 5% CO2 /95% air, at 37 ◦C.  
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2.4.Determination of FSDC viability by the MTT assay 2.8.Immunocytochemistry assay 
 
FSDC were exposed, for 24 h, to the tested chemicals in a dose response 
experiment and analyzed for viability by the reduction of the tetrazolium  
bromide salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
(Mosmann, 1983). Briefly, FSDC were plated at 0.2 × 106 cells/well in 48-well plates 
in a final IMDM volume of 400 l and stock solutions of chemi 
cals were added to obtain the different final in-well concentrations studied. After 23h 
exposure, 40 l of MTT solution (5 mg/ml) was added to each well and cells were further 
incubated at 37 ◦C for 1 h. Finally, the supernatants were discarded and 300 l of acidic 
isopropanol was added to the cells. Formazan quantification 
was performed using an automatic plate reader (SLT, Austria) at 570 nm, with a 
reference wavelength of 620 nm. 
 
2.5.Chemical treatment 
 
At day 7 of culture, immature MoDC were harvested by centrifugation, resus 
pended in fresh cytokines containing medium and plated at 0.3 × 106 cells/well  
in 24-well plates. FSDC were collected by trypsinization, resuspended in fresh  
IMDM medium and plated at 2 × 106 cells/well in six-well microplates, or at  
125× 103 cells/cm2 in Lab-Tek Chamber Slides, for Western blot analysis and  
immunocytochemistry, respectively. The cells were incubated overnight, prior to  
chemical exposure. After this period, stock solutions were added to obtain a final  
in-well concentration of 5 g/ml LPS, 1 g/ml DNFB, 50 g/ml PPD, 50 g/ml 
NiSO4 , 1 g/ml DCNB, 50 g/ml SDS and 1 g/ml BC. SDS, BC, PPD and NiSO4 were 
dissolved in PBS, while DNFB and DCNB were first solubilised in dimethyl 
sulphoxide and subsequent dilutions were performed in PBS. The final concentration 
of dimethyl sulphoxide never exceeded 0.01% (v/v), and was without effect on cell 
viability and on CXCR4 and CD40 expression (data not shown). Control experiments 
consisted in non-treated cells. 
 
2.6.Cell lysate preparation 
 
To prepare total cell lysates for Western blot analysis, after 24 h of chemical 
stimulation, cells were washed with ice-cold PBS and harvested in a sonication buffer 
containing 0.25 M sucrose, 10 mM Tris-HCl (pH 7.5), 1 mM 
ethylenediaminetetraacetic acid, 1 mM dithiothreitol, 10 mM sodium fluoride and a 
protease inhibitor cocktail. The lysates were then incubated on ice, for 30 min, and 
sonicated four times, for 4 s at 40 m in a Vibra Cell sonicator (Sonics & 
Material INC), to disrupt the cells. Protein concentration was determined using the 
bicinchoninic acid method and the cell lysates were denatured at 100 ◦C, for 7min, in 
sample buffer (0.125 mM Tris pH 6.8; 2% (w/v) SDS; 100 mM DTT; 10%glycerol 
and bromophenol blue). 
 
2.7.Western blot analysis 
 
Western blot was performed to evaluate CXCR4 and CD40 protein levels.  
Briefly, each gel was loaded always with the same amount of protein which  
was 60 or 80 (depending on the amount of protein available). The proteins were  
electrophoretically separated on a 12% (v/v) SDS-PAGE, and transferred to a  
PVDF membrane. The membranes were blocked with 5% (w/v) fat-free dry  
milk in Tris-buffered saline containing 0.1% (v/v) Tween 20 (TBS-T), for 1 h  
at room temperature. Blots were then incubated, for 1 h at room temperature,  
with a rabbit polyclonal anti-CXCR4 antibody (1:1000) or a rat monoclonal  
anti-mouse CD40 antibody (1:500), washed for 25 min with 1% (w/v) fat 
free dry milk in TBS-T, and incubated, for 1 h, at room temperature, with a  
alkaline phosphatase-conjugated anti-rabbit antibody (1:20,000), or a alkaline  
phosphatase-conjugated anti-rat antibody (1:10,000), respectively. The immune  
complexes were detected by membrane exposure to the ECF reagent, dur 
ing 8 min, followed by scanning for blue excited fluorescence on the Storm  
860 (GE Healthcare). The generated signals were analyzed using the Image 
Quant TL software. To ensure that there were similar amounts of protein  
in each sample, the membranes were stripped, reprobed with a monoclonal  
anti-actin antibody (1:10,000), and developed with an alkaline phosphatase 
conjugated anti-mouse antibody (1:20,000), by enhanced chemifluo 
rescence. 
The effect of skin sensitizers and irritants on the expression of the CXCR4 
protein was also evaluated by immunocytochemistry analysis. FSDC, cultured in  
Lab-Tek Chamber Slides and stimulated as described above, were washed with  
ice-cold PBS and fixed and permeabilized with cold methanol:acetone (1:1),  
for 10 min. The cells were then incubated for 1 h at 4 ◦C, with a rabbit poly 
clonal anti-CXCR4 antibody (1:200), washed three times with PBS, for 5 min,  
and incubated, for 1 h at room temperature, with Alexa 488-conjugated goat  
anti-rabbit antibody (1:500). After a new washing step, the cells were mounted  
with Vectashield mounting medium to reduce the photobleaching. Negative con 
trol experiments consisted of processing the same preparations as described  
above, except for the omission of the primary antibody, resulting in weak non 
specific staining. Fluorescence labelling was visualized using a Zeiss Axiovert  
200microscope, and images captured with a coupled AxioCamHR camera.  
In each experiment, the optimal acquisition parameters were defined for the  
control cells and then maintained for all the other conditions within the same  
experiment. 
2.9.Data analysis 
The results are presented as mean ± S.E. of the indicated number of  
experiments, and the means were statistically compared using the One-Way  
ANOVA test, with a Dunnett’s post-test. The significance level was *p < 0.05, **  
p < 0.01. 
3.Results 
3.1.Effect of skin sensitizers and irritants on the viability of FSDC: 
determination of optimal chemicals concentrations 
Since it has been shown that cytotoxicity may play a relevant  
role in DC activation (Hulette et al., 2005) we considered as opti 
mal chemicals concentrations those that induced up to 10-15%  
cytotoxicity. Considering this criterion, the selected concentra 
tions were 1 g/ml DNFB, 50 g/ml PPD, 50 g/ml NiSO4 , 
1 g/ml DCNB, 50 g/ml SDS and 1 g/ml BC (Fig. 1). As shown in 
Fig. 1, increasing concentrations of the allergen PPD caused an 
apparent increase of cell viability, but in fact this is due to a direct 
interaction of PPD with the reagent MTT, which causes an increase 
in the absorbance values. Therefore, 
Fig. 1. Effects of chemicals on FSDC viability: determination of optimal con 
centrations. FSDC were incubated, for 24 h, In culture medium in the absence  
(control), or in the presence of different concentrations of the indicated chem 
icals. After this period, the cell viability was assessed by the MTT assay, as  
described in “Section 2”. Results are expressed as a percentage of MTT reduc 
tion by control cells, maintained in culture medium. The horizontal black dashed  
line indicates the limit of 85% of control (viability criterion). Each value repre 
sents the mean ± S.E. from three independent experiments, each one performed  
in duplicate.  
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for this sensitizer we accessed the cell viability by the Trypan Table 1 
Blue exclusion assay (data not shown). Modulation of CXCR4 protein levels by LPS, PPD and SDS in human monocyte 
 derived dendritic cells 
3.2.Effect of skin sensitizers and irritants on CXCR4 
protein levels in FSDC 
 
After FSDC exposure, during 24h, to three skin sen 
sitizers and two irritants, the changes in CXCR4 protein  
levels were determined by Western blot. As shown in Fig. 2  
(lanes 2, 3 and 4), CXCR4 protein levels were significantly  
increased after cell treatment with all the skin sensitizers tested,  
namely DNFB, PPD and NiSO4, by 44.4 ± 7.1%, 54.7 ± 3.6%  
and 18.1 ± 1.8%, respectively. In contrast, exposure to irri 
tants resulted in a marked down-regulation of CXCR4, by  
65.0± 6.8% or 69.2 ± 5.8%, for SDS and BC, respectively.  
When the cells were incubated with the non-sensitizer DCNB  
no effect was observed on CXCR4 protein levels (Fig. 2, lane  
5). 
Immunofluorescence microscopy experiments confirmed these 
results and showed an up-regulation of CXCR4 induced by all the 
sensitizers tested (Fig. 2c). Interestingly, these increases in CXCR4 
immunoreactivity were predominantly observed at an intracellular level. 
Immunofluorescence labelling of FSDC cells also confirmed that the 
non-sensitizer DCNB had no significant effect on CXCR4 protein 
levels. 
LPS  PPD  SDS 
Donor 1  ↑ ↑  ↑  ↓ 
Donor 2  ↑  ↑ ↑  ↓ ↓ 
Donor 3  ↑ ↑  ↑ ↑ ↑  ↑ 
↑ =slightly increased; ↑ ↑ = increased; ↑ ↑ ↑ = strongly increased; ↓ = slightly 
decreased; ↓ ↓ = decreased. 
3.3.Effect of LPS, PPD and SDS on CXCR4 protein levels in 
MoDC 
The effect of sensitizers and irritants on CXCR4 protein levels in 
FSDC was confirmed in monocyte-derived dendritic cells. The cells 
were stimulated with the sensitizer PPD or with the irritant SDS, and 
lipopolysaccharide was used as a positive control since it is known 
to induce MoDC activation and up-regulation of maturation markers 
(Verhasselt et al., 1997; Hulette et al., 2002).Each experiment was 
conducted with cells isolated from blood of a single donor, 
differentiated in IL-4 and GM-CSF containing medium for 7 days, 
and subsequently exposed to stimuli for 24 h. CXCR4 protein was then 
quantified by Western blot analysis. Exposure of cells to the sensitizer 
PPD resulted in increased levels of the receptor in all experiments, 
while treat 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Skin sensitizers and irritants have opposite effects on CXCR4 protein levels in FSDC. (a) FSDC cells (2 × 106 cells) were incubated, for 24 h, in culture  
medium in the absence (control, lane 1) or in the presence of 1 g/ml DNFB, 50 g/ml PPD, 50 g/ml NiSO4 , 1 g/ml DCNB, 50 g/ml SDS or 1 g/ml BC. Equal  
amounts of protein, obtained from total cell extracts, were loaded on 12% SDS-polyacrylamide gels, subjected to electophoresis and electrotransferred to PVDF  
membranes. Immunoblotting of CXCR4 protein was performed using an anti-CXCR4 antibody, as described in “Section 2”. To ensure that there were similar amounts  
of protein in each sample, the membranes were stripped, reprobed with a monoclonal anti-actin antibody (1:10,000), and developed with an alkaline phosphatase 
conjugated anti-mouse antibody (1:20,000). The blot shown is representative of nine independent experiments yielding similar results. (b) The optical densities of  
the bands were obtained by scanning the membranes in a fluorescence scanner, and then analysed with the ImageQuant TL Software. The results were expressed as  
%of CXCR4 expression relatively to control. Each value represents the mean ± S.E. from nine independent experiments (*p < 0.05; **p < 0.01 as compared to the  
control). (c) Immunofluorescence analysis of the effect of skin sensitizers and irritants on CXCR4 protein levels. FSDC cells (125 × 103 cells/cm2 ) were incubated  
on Lab-Tek Chamber Slides, under the same conditions as described for Western blot analysis. Immunostaining was performed as described in “Section 2”. The  
images were acquired with an AxioCamHR camera, coupled to a Zeiss Axiovert 200 microscope and analyzed with AxioVision v.4.5 software. The images shown  
are representative of three individual experiments yielding similar results. Scale bar = 50 m.  
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Fig. 2.  (Continued )  
 
 
ment with the irritant SDS caused a reduction in two of the els of CXCR4 protein in all the experiments performed. In spite 
three assays (Table 1). This response pattern (Fig. 3) is similar of the reproducibility of the MoDC responses, their magnitudes 
to the one obtained in FSDC, indicating that only the sensitizer varied considerably between experiments. Therefore, the results 
tested is able to increase CXCR4 expression in both cell models. were not statistically treated and are presented in a qualitative 
Accordingly, LPS-matured MoDC also presented increased lev form. 
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Fig. 3. MoDC exposed to the sensitizer PPD and the irritant SDS show a CXCR4 
response pattern similar to that one obtained in FSDC. (a) MoDC were obtained by 
culturing human monocytes in GM-CSF and IL-4-supplemented culture medium, for 7 
days, as described in “Section 2”. Cells (0.3 × 106 cells) were then incubated, for 24 h, in 
culture medium, in the absence (control, lane 1) or in the presence of 5 g/ml LPS, 50 
g/ml PPD, or 50 g/ml SDS. Equal amounts of protein, obtained from total cell extracts, 
were loaded on 12% SDSpolyacrylamide gels, subjected to electophoresis and 
electrotransferred to PVDF membranes. Immunoblotting of CXCR4 protein was 
performed using an antiCXCR4 antibody. To ensure that there were similar amounts of 
protein in each sample, the membranes were stripped, reprobed with a monoclonal anti-
actin antibody (1:10,000), and developed with an alkaline phosphatase-conjugated anti-
mouse antibody (1:20,000). The blot shown is representative of the CXCR4 response 
pattern to sensitizers and irritants in three independent experiments. (b) The optical 
densities of the bands were obtained by scanning the membranes in a fluorescence 
scanner, and then analysed with the ImageQuant TL Software. The results were 
qualitatively expressed in Table 1 as increases or decreases of  
CXCR4 protein levels relatively to the control cells. Fig. 4. Skin sensitizers increase CD40 protein levels in FSDC. (a) FSDC cells 
 (2× 106 cells) were incubated, for 24 h, in culture medium in the absence (con 
3.4.Effect of skin sensitizers and irritants on CD40 protein 
levels in FSDC 
 
Stimulation of cells with the skin sensitizers DNFB and PPD  
significantly increased the CD40 protein levels, by 25.7 ± 3.4%  
and 47.2 ± 12.4%, respectively, whereas exposure to NiSO4  
resulted in a non-statistically significant increase of 13.1 ± 2.0%  
(Fig. 4, lanes 2, 3 and 4). Similarly to CXCR4, cell exposure  
to NiSO4 resulted in a smaller but very reproducible increase in  
CD40 protein levels. In contrast to skin sensitizers, both irritants  
tested, SDS and BC, decreased CD40 levels by 21.6 ± 2.2% and  
42.8± 4.5%, respectively (Fig. 4, lanes 6 and 7). Again, no effect  
was found after treatment with the non-sensitizer DCNB (Fig. 4,  
lane 5). 
 
4.Discussion 
 
The development of in vitro methods for predicting the sen 
sitizing potential of new chemicals is of major importance for  
the reduction of animal testing and the maintenance of product  
safety. Several approaches, with different levels of complex 
ity, have been described. Some of the most promising assays  
are based on the use of dendritic-like cell cultures in order to  
reconstitute the maturation process of Langerhans cells after  
exposure to sensitizers, by monitoring activation markers such  
as CD86, CD83, CD40 and CD54. However, owing to the vari 
ability reported in many of the surface markers studied to date,  
it is appropriate to consider alternative experimental strategies,  
including the use of other DC models and assessment of new  
possible markers. 
In the present study, the potential use of the FSDC cell  
line to discriminate between skin sensitizers, irritants and 
nonsensitizers was evaluated for the first time, and the results  
obtained were compared with the response of human monocytederived 
dendritic cells. In contrast to other DC-cell lines, FSDC 
trol, lane 1) or in the presence of 1 g/ml DNFB, 50 g/ml PPD, 50 g/ml 
NiSO4 , 1 g/ml DCNB, 50 g/ml SDS or 1 g/ml BC. Equal amounts of pro 
tein, obtained from total cell extracts, were loaded on 12% SDS-polyacrylamide  
gels, subjected to electophoresis and electrotransferred to PVDF membranes.  
Immunoblotting of CD40 protein was performed using an anti-CD40 antibody,  
as described in “Section 2”. To ensure that there were similar amounts of pro 
tein in each sample, the membranes were stripped, reprobed with a monoclonal  
anti-actin antibody (1:10,000), and developed with an alkaline phosphatase 
conjugated anti-mouse antibody (1:20,000). The blot shown is representative of  
three independent experiments yielding similar results. (b) The optical densi 
ties of the bands were obtained by scanning the membranes in a fluorescence  
scanner, and then analysed with the ImageQuant TL Software. The results were  
expressed as % of CD40 expression relatively to control. Each value represents  
the mean ± S.E. from three independent experiments (*p < 0.05; **p < 0.01 as  
compared to the control). 
is cultured in the absence of exogenous growth factors and  
has a surface phenotype consistent with that of a Langerhans  
cell progenitor (H-2d.b+ , I-Ad.b+ , CD54+ , MHCII+ , MHCI+ ,  
CD11c+, CD11b+, B7.2+ , CD44+ B220−, CD3−). This cell line  
has been previously used as an immature DC model (Mann et  
al., 2002; Egan et al., 2004). Upon treatment with cytokines,  
FSDC stimulate allogeneic or syngeneic T-cells in the primary  
mixed-leukocyte reaction and present haptens to primed T-cells  
in vitro. Moreover, FSDC derivatized with haptens and injected  
either intravenously or subcutaneously efficiently induce con 
tact sensitivity responses in na¨ve syngeneic mice (Girolomoni  
et al., 1995). Using this cell line as an immature DC model, we  
analyzed the effect of the sensitizers DNFB, PPD and NiSO4 ,  
the non-sensitizer DCNB and the irritants SDS and BC, on  
the protein levels of the chemokine receptor CXCR4 and the  
co-stimulatory molecule CD40. The results were correlated  
with those obtained following exposure of human monocyte 
derived dendritic cells to LPS, to the sensitizer PPD and to  
the irritant SDS. Since the CD40 co-stimulatory molecule is  
a well-established MoDC maturation marker (Ryan et al., 2007)  
we focused our analysis on the CXCR4 receptor. Our results  
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demonstrated that all of the skin sensitizers increased CXCR4 The SDF-1-CXCR4 axis is commonly associated with cell 
and CD40 protein levels in FSDC, in contrast with the effect 
of the irritants tested, which decreased both proteins. Further 
more, this CXCR4 response pattern was also observed in MoDC  
for the allergen (PPD) and irritant (SDS) tested in both cell  
models. 
In this work we evaluated, for the first time, the potential  
utilization of CXCR4 as a biomarker to discriminate sensitiz 
ers from irritants. We observed that total CXCR4 protein levels  
were significantly increased after FSDC treatment with sensitiz 
ers, in contrast with the effect of irritants, which caused marked  
reductions (Fig. 2). Furthermore, this response pattern was also  
observed in MoDC, in which two of the three independent exper 
iments demonstrated a pattern very similar to that one obtained  
in FSDC (Fig. 3). MoDC exposure to LPS and PPD led to an  
up-regulation of the protein in all experiments, although with  
variable response magnitudes between donors (Table 1). This  
variability of MoDC responsiveness was previously reported  
in many studies and attributed to inter-individual variability  
and/or to the expression heterogeneity of the analysed molecules  
(Aiba et al., 1997; Lin et al., 1998; Pichowski et al., 2000). The  
observed similarity between the response patterns of the two  
cell models tested suggests that, as described by other authors  
for MoDC (Hulette et al., 2002; Jugde et al., 2005; Toebak et al.,  
2006),FSDC were also activated by sensitizers and not by irri 
tants. Another evidence that the CXCR4 receptor is modulated  
by the maturation state of DC was highlighted in recent works,  
which showed, through genomic analysis, that transcription of  
CXCR4 gene was slightly up-regulated on MoDC (Ryan et al.,  
2004)and CD34+ derived DC (Schoeters et al., 2006) after cells  
exposure to the contact sensitizers dinitrobenzenesulfonic acid  
and NiSO4, respectively. 
Immunochemistry analysis of FSDC confirmed the Western  
blot results, and showed an up-regulation of CXCR4 induced by  
all the sensitizers tested, being this increases mainly observed at  
an intracellular level (Fig. 2c). These results are very interesting  
since in a flow cytometric study, significant decreases in CXCR4  
surface expression were reported after FSDC exposure to DNFB,  
NiSO4 or the DC maturation stimulus LPS (Cruz et al., 2005).  
Moreover, in a work performed with MoDC, it was shown that,  
in spite of the up-regulation of CXCR4 mRNA in LPS-matured  
DC, the receptor was not detectable at the cell surface and the  
cells did not respond to SDF-1 (Sallusto et al., 1998). However,  
when mature cells were washed and recultured in fresh medium  
without LPS, a recovery of the chemokine receptor was observed  
both in terms of surface expression and response to agonist. The  
authors discussed that this discrepancy between mRNA levels  
and surface receptor expression might be due to the produc 
tion of the CXCR4 ligand SDF-1 by maturing DC, resulting in  
desensitization of the CXCR4 receptors (Sallusto et al., 1998).  
Accordingly, the difference between the total CXCR4 protein  
levels and its surface expression in sensitizers-treated FSDC  
might be the result of a ligand-independent intracellular seques 
tration or of a desensitization process, in which matured FSDC  
produce SDF-1 that directly activates the receptor causing its  
internalization. These hypotheses are under current investigation  
in our lab. 
trafficking, and the migratory capacities of DC are intimately 
related to their ability to switch the chemokine receptor reper 
toire according to their maturation state. Upon exposure to  
maturation stimuli, DC up-regulate the surface expression of  
CCR7 and CXCR4, gaining responsiveness to the chemokines  
CCL21, CCL19 and SDF-1, which drive their migration to the  
T-cell areas of draining lymph nodes (McColl, 2002). In contrast  
with CCR7, which has an established role in the migration of  
mature DC (Ohl et al., 2004; Humrich et al., 2006), the contri 
bution of CXCR4 is still far from being elucidated. However,  
from a physiopathologic point of view, CXCR4 may play a role  
in the initial phase of ACD. Given that SDF-1 is also expressed  
in inflamed tissues, the triggering of DC maturation by exoge 
nous stimuli, such sensitizers or LPS, causes an initial CXCR4  
receptor internalization, allowing DC to leave the site of inflam 
mation. Subsequently, during migration, the receptor recycles  
back to the membrane and may act synergistically with CCR7  
to drive DC to T-cell areas of secondary lymphoid organs. Since  
CXCR4 andCCR7 are expressed not only on mature DC but also  
on naive T-cells, this will favour the co-localization of these cells  
at sites where SDF-1, CCL19 and CCL21 are produced. In addi 
tion to this role in the migratory capacities of DC, CXCR4 could  
also be responsible for inhibition of apoptosis during the early  
phase of DC activation at the site of inflammation and/or during  
the migration of mature DC to the lymph nodes (Humrich et  
al., 2006). Accordingly, CXCR4 has recently been shown to be  
involved in DC survival (Kabashima et al., 2007).  
 In present work we also analysed the effect of three sensitiz 
ers and two irritants on the expression of CD40 co-stimulatory  
molecule in FSDC. We found that all the sensitizers tested  
increased CD40 protein levels, although with different magni 
tudes (Fig. 4). This may reflect the different sensitizing potency  
of the chemicals, since DNFB and PPD have stronger in vivo  
and in vitro activity than NiSO4 . Accordingly, our previous  
works showed an up-regulation of this co-stimulatory molecule  
after treatment of the FSDC with the sensitizers DNFB and  
NiSO4, being the strongest effect induced by DNFB (Matos  
et al., 2005; Vital et al., 2004). Exposure of MoDC cells to  
the allergens 4-aminophenol, chlorpromazine hydrochloride,  
2,4-dinitrochlorobenzene and NiSO4 also increased surface  
expression of CD40, while the irritants SDS and benzoic acid  
were without effect (Coutant et al., 1999). An up-regulation of  
CD40 was also observed following stimulation of MoDC with  
the DC maturation stimuli LPS, TNF- and with the contact  
sensitizer NiSO4 (Arrighi et al., 2001). The use of an alterna 
tive cytokine cocktail to generate DC from monocytes, namely  
GM-CSF, IL-4 and TGF- 1, which polarize DC differentiation  
towards the LC pathway, also showed that NiSO4 and DNCB  
induced the up-regulation of molecules involved in antigen pre 
sentation, namely CD40 (Staquet et al., 2004). Furthermore,  
treatment of the human myeloid cell line MUTZ-3 with moder 
ate or strong/extreme sensitizers also up-regulates CD86, CD54,  
CD40, and B7-H1 in a dose-dependent manner (Azam et al.,  
2006).Taking together, the results obtained using different LC 
like cell models highlight the CD40 co-stimulatory molecule as  
a maturation marker.  
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Previous reports showed the pivotal role of CD40-CD40 lig 1human monocyte cells as predictive endpoints for contact sensitizers. 
and interactions in the initiation of acquired antigen-specific 
T-cell mediated immunity. CD40 activation by its ligand is  
critical for maintaining DC viability, to promote their matu 
ration through up-regulation of adhesion and co-stimulatory  
molecules, which enhances T-cell stimulatory capacity, and to  
control their migration to the draining lymph nodes (Cella et  
al., 1996; Moodycliffe et al., 2000). The CD40-CD40L inter 
action also activates cytokine expression in DC and promotes  
IL-6 and IL-12 secretion, which are important in driving T-cell  
response (Mann et al., 2002; Wesa and Galy, 2002). Moreover,  
ex vivo experiments showed that CD40 is up-regulated in LC  
isolated from mice sensitized with trinitrochlorobenzene (Aiba,  
1998).Therefore, CD40 could be regarded as a marker of DC  
activation, which is in agreement with our results obtained in  
the FSDC cell line showing that only skin sensitizers increased  
CD40 protein levels. Reinforcing this idea, we found that DCNB,  
the inactive structural analogue of DNFB, had no significant  
effect on the CD40 protein levels, while the irritants SDS and  
BC down-regulate this co-stimulatory molecule (Fig. 4).  
 In summary, we observed that exposure of FSDC to three dif 
ferent sensitizers increased the CXCR4 and CD40 protein levels,  
whereas the irritants, SDS and BC, caused the opposite effect.  
Therefore, their evaluation may constitute a useful parameter for  
discriminating between sensitizers and irritants. The increase of  
CXCR4 protein caused by the sensitizer PPD was also observed  
in MoDC. Furthermore, our data suggest that evaluation of the  
total CXCR4 protein levels is more reliable than the analysis  
of surface expression, since the receptor appears to be internal 
ized in the presence of maturation stimuli and recycled to the  
membrane in a later phase. Finally, the use of the FSDC cell line  
as a LC-like cell model may represent a useful tool in a future  
in vitro test for sensitizing assessment. We are now evaluating  
other chemicals and DC maturation markers in FSDC, in order  
to extend the data about their capacities to discriminate between  
skin sensitizers and irritants. 
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